Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. (Q30275266)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. |
scientific article |
Statements
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial (English)
Matthew D Galsky
Jonathan E Rosenberg
Thomas Powles
Daniel P Petrylak
Joaquim Bellmunt
Yohann Loriot
Jean Hoffman-Censits
Jose Luis Perez-Gracia
Nancy A Dawson
Michiel S van der Heijden
Robert Dreicer
Sandy Srinivas
Margitta M Retz
Alexandra Drakaki
Ulka N Vaishampayan
Srikala S Sridhar
David I Quinn
Ignacio Durán
David R Shaffer
Petros D Grivas
Evan Y Yu
Shi Li
Edward E Kadel
Zachary Boyd
Priti S Hegde
Sanjeev Mariathasan
AnnChristine Thåström
Oyewale O Abidoye
Gregg D Fine
Dean F Bajorin
IMvigor210 Study Group